Treatment of bacterial endocarditis 1976.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000601:surgery; D013293:Enterococcus faecalis; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes; D013298:Streptococcus sanguis; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D005672:Fusidic Acid; D014640:Vancomycin; D008034:Lincomycin